Skip to main content
GH logo

GH · Guardant Health, Inc. · Analyst Estimates

Track GH — free
$177.05 -0.11 (-0.06%)
Market Cap
$24.57B
Shares
134.20M

Analyst Estimates

Compare analyst forecasts for Guardant Health, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-22 21:42 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.81023
-1.46466
-1.18
-1.45449
-1.39457
-1.46466
-1.41537
EPS
analysts
Publication date not stated
22
11
1
6
0
Revenue
USD
Publication date not stated
1347702070
1357657280
1371332840
Revenue
analysts
Publication date not stated
26

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.43
-0.39803
0.70714
-0.45013
-0.4332
-0.39803
-0.53029
EPS
analysts
Publication date not stated
20
8
0
10
1
Revenue
USD
Publication date not stated
1718739000
1839752450
2083300000
Revenue
analysts
Publication date not stated
26

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.39
-0.30727
-0.22
-0.30182
-0.30086
-0.30727
-0.30236
EPS
analysts
Publication date not stated
18
8
1
8
0
Revenue
USD
Publication date not stated
344300000
350708760
357000000
Revenue
analysts
Publication date not stated
21

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.57011
-0.28082
-0.17
-0.2853
-0.27339
-0.28082
-0.27671
EPS
analysts
Publication date not stated
18
9
0
7
1
Revenue
USD
Publication date not stated
364000000
369522130
380400000
Revenue
analysts
Publication date not stated
21
Key facts CIK 1576280 CUSIP 40131M109 13F (30d) 15 filings 14 filers Visit website Investor relations